Enzyme promiscuity: engine of evolutionary innovation C Pandya, JD Farelli, D Dunaway-Mariano, KN Allen Journal of Biological Chemistry 289 (44), 30229-30236, 2014 | 159 | 2014 |
Panoramic view of a superfamily of phosphatases through substrate profiling H Huang, C Pandya, C Liu, NF Al-Obaidi, M Wang, L Zheng, ... Proceedings of the National Academy of Sciences 112 (16), E1974-E1983, 2015 | 153 | 2015 |
Genomic profiling reveals mutational landscape in parathyroid carcinomas C Pandya, AV Uzilov, J Bellizzi, CY Lau, AS Moe, M Strahl, W Hamou, ... JCI insight 2 (6), 2017 | 101 | 2017 |
Development and clinical application of an integrative genomic approach to personalized cancer therapy AV Uzilov, W Ding, MY Fink, Y Antipin, AS Brohl, C Davis, CY Lau, ... Genome medicine 8, 1-20, 2016 | 99 | 2016 |
Divergence of Structure and Function in the Haloacid Dehalogenase Enzyme Superfamily: Bacteroides thetaiotaomicron BT2127 Is an Inorganic Pyrophosphatase H Huang, Y Patskovsky, R Toro, JD Farelli, C Pandya, SC Almo, KN Allen, ... Biochemistry 50 (41), 8937-8949, 2011 | 47 | 2011 |
Consequences of domain insertion on sequence-structure divergence in a superfold C Pandya, S Brown, U Pieper, A Sali, D Dunaway-Mariano, PC Babbitt, ... Proceedings of the National Academy of Sciences 110 (36), E3381-E3387, 2013 | 32 | 2013 |
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma E Bangi, P Smibert, AV Uzilov, AG Teague, S Gopinath, Y Antipin, R Chen, ... Iscience 24 (3), 2021 | 20 | 2021 |
RAPiD—an agile and dependable RNA-Seq framework H Shah, YC Wang, R Castellanos, C Pandya, Z Giles The 65th Annual Meeting of The American Society of Human Genetics, 2015 | 17 | 2015 |
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma AV Uzilov, KC Cheesman, MY Fink, LC Newman, C Pandya, Y Lalazar, ... Molecular Case Studies 3 (3), a001602, 2017 | 13 | 2017 |
Molecular and phenotypic profiling of drug product and post-infusion samples from CRB-402, an ongoing: Phase I Clinical Study of bb21217 a BCMA-directed CAR T cell therapy OC Finney, A Yeri, P Mao, C Pandya, E Alonzo, G Hopkins, S Hymson, ... Blood 136, 3-4, 2020 | 12 | 2020 |
Parafibromin abnormalities in ossifying fibroma J Costa-Guda, C Pandya, M Strahl, P Taik, R Sebra, R Chen, AV Uzilov, ... Journal of the Endocrine Society 5 (7), bvab087, 2021 | 8 | 2021 |
Structure‐guided approach for detecting large domain inserts in protein sequences as illustrated using the haloacid dehalogenase superfamily C Pandya, D Dunaway‐Mariano, Y Xia, KN Allen Proteins: Structure, Function, and Bioinformatics 82 (9), 1896-1906, 2014 | 6 | 2014 |
Markers of initial and long-term responses to idecabtagene vicleucel (Ide-Cel; bb2121) in the CRB-401 Study in Relapsed/Refractory Multiple Myeloma EG Thompson, Y Jiang, TB Campbell, J Fuller, S Kaiser, ... Blood 134, 4328, 2019 | 3 | 2019 |
Correlative Analysis from CRB-402: An Ongoing Phase 1 Clinical Study of bb21217 Anti-BCMA CAR T Cell Therapy OC Finney, A Yeri, C Pandya, E Alonzo, K Endelberg, G Hopkins, A Ladd, ... MOLECULAR THERAPY 28 (4), 575-575, 2020 | 1 | 2020 |